|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$422,717
|
$84,543
|
Hickstein, Dennis
|
CCR (NCI)
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
2P30CA016359-34
|
$2,531,005
|
$227,790
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-34S1
|
$75,000
|
$6,750
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
Xenograft Model to Study Impact of CRLF2-Ligand in Hispanic Childhood B-ALL
|
5R21CA162259-02
|
$151,804
|
$151,804
|
PAYNE, KIMBERLY
|
LOMA LINDA UNIVERSITY
|
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-16
|
$320,126
|
$9,604
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-13
|
$1,336,045
|
$160,325
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-05S2
|
$37,430
|
$1,123
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-05
|
$1,396,397
|
$41,892
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
6R01CA044722-23
|
$191,385
|
$191,385
|
Studzinski, George
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$52,897
|
$5,290
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
|
Validation of microRNAs as therapeutic targets in hematological malignancies
|
5R01CA135332-03
|
$297,452
|
$297,452
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
|
Validation and Development of WEE1 as a therapeutic target in AML
|
1R01CA172385-01A1
|
$314,255
|
$314,255
|
PORTER, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-05
|
$331,098
|
$331,098
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
|
Validating a novel biomarker of clinical progression and survival in CLL
|
5R33CA161731-03
|
$364,740
|
$364,740
|
DAVIS, RANDALL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-39
|
$4,133,528
|
$82,671
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S1
|
$37,429
|
$749
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S2
|
$122,414
|
$2,448
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Using game mechanics to improve outcomes among stem cell transplant survivors
|
3R41CA168107-01S1
|
$149,145
|
$74,573
|
McLaughlin, Jeffery
|
RADIANT CREATIVE GROUP, LLC
|
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-27
|
$1,397,496
|
$111,800
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-29
|
$2,114,386
|
$21,144
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-09S1
|
$75,000
|
$25,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-09S2
|
$112,521
|
$38,257
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-09
|
$1,808,387
|
$614,852
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S1
|
$74,531
|
$5,217
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S2
|
$49,999
|
$3,500
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-25
|
$5,801,264
|
$406,088
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-06
|
$1,463,426
|
$43,903
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
1P30CA177558-01
|
$1,402,503
|
$98,175
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-01S1
|
$75,000
|
$5,250
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-26
|
$1
|
$0
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S1
|
$25,000
|
$1,500
|
Greenfield, Sheldon
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S2
|
$49,980
|
$2,999
|
Greenfield, Sheldon
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
University of California, Irvine Cancer Center Support Grant
|
5P30CA062203-18
|
$1,168,116
|
$70,087
|
Van Etten, Richard
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$224,566
|
$89,826
|
Fowler, Daniel
|
CCR (NCI)
|
|
|
Understanding Hemotopoietic Neoplasias using Humanized Mice
|
5R01CA156689-04
|
$461,009
|
$230,505
|
Flavell, Richard
|
YALE UNIVERSITY
|
|
|
UMass Boston-DF/HCC U54 Partnership (2 of 2)
|
3U54CA156734-04S1
|
$63,750
|
$31,875
|
Colon-Carmona, Adan
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
|
UMass Boston-DF/HCC U54 Partnership (2 of 2)
|
5U54CA156734-04
|
$1,156,260
|
$578,130
|
Colon-Carmona, Adan
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
|
U10 Full Member Application Affiliated with SWOG
|
5U10CA105409-10
|
$341,201
|
$10,236
|
Eng, Cathy
|
UT MD ANDERSON CANCER CTR
|
|
|
Tyrosine Kinase Signaling in Cancer Cell Metabolism
|
5R01CA140515-04
|
$296,324
|
$296,324
|
Chen, Jing
|
EMORY UNIVERSITY
|
|
|
Tyrosine Kinase Regulation Via Protein Degradation
|
5R01CA087986-15
|
$253,133
|
$253,133
|
Band, Hamid
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-04
|
$317,854
|
$317,854
|
Baker, Sharyn
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Tumor-toxic CD47 mAb therapy for leukemia: a proof of concept study
|
1R41CA176880-01
|
$299,687
|
$299,687
|
FRAZIER, WILLIAM
|
VASCULOX, INC.
|
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$336,277
|
$33,628
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
|
Tulane Medical/Cancer Center Minority-Based Community Clinical Oncology Program
|
5U10CA167782-02
|
$663,700
|
$59,733
|
Robinson, William
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
Trisomy 8 in hematopoiesis and myeloid leukemia
|
5K08CA160346-03
|
$170,100
|
$170,100
|
Gordon, David
|
DANA-FARBER CANCER INST
|
|
|
Transposon Insertion Polymorphisms in Predispositions to Hematopoietic Neoplasia
|
1R01CA163705-01A1
|
$336,150
|
$168,075
|
BURNS, KATHLEEN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
|
5R01CA154998-03
|
$283,089
|
$283,089
|
Farrar, Michael
|
UNIVERSITY OF MINNESOTA
|
|
|
Transplant Models
|
ZIA BC 010957
|
$764,570
|
$267,599
|
Gress, Ronald
|
CCR (NCI)
|
|
|
Translational Research in Cancer
|
2P30CA056036-14
|
$2,647,679
|
$105,907
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Translational Research in Cancer
|
3P30CA056036-14S1
|
$73,216
|
$2,929
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Total relevant funding to Leukemia for this search: $234,861,010
|
